← FDA Drug Approvals (Drugs@FDA)

EPTIFIBATIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SLATE RUN PHARMA · Approved 2019-01-25

Drug application

FDA Application #

ANDA209864

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPTIFIBATIDE

Generic name

EPTIFIBATIDE

Active ingredients

EPTIFIBATIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SLATE RUN PHARMA

Manufacturer

Slate Run Pharmaceuticals, LLC

First approval

2019-01-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown